Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Acidosis D000138 13 associated lipids
Abortion, Habitual D000026 5 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ansari HR et al. Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17921329
Ivandic BT et al. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. 2007 Clin. Chem. pmid:17332149
Calzada C et al. In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. 2007 J. Clin. Endocrinol. Metab. pmid:17341567
Eligini S et al. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. 2007 Cardiovasc. Res. pmid:17250815
Faraday N et al. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. 2007 Circulation pmid:17470694
Luceri C et al. p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. 2007 Br. J. Nutr. pmid:17313706
Basselin M et al. Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. 2007 Biol. Psychiatry pmid:17628508
Bray PF et al. Heritability of platelet function in families with premature coronary artery disease. 2007 J. Thromb. Haemost. pmid:17663734
Chang MC et al. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. 2007 Br. J. Pharmacol. pmid:17641677
Liu J et al. FcRgamma-chain signals in the absence of glycoprotein VI. 2007 J. Thromb. Haemost. pmid:17010148
Holma R et al. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. 2007 J. Physiol. Pharmacol. pmid:17928642
Dawood MY and Khan-Dawood FS Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. 2007 Prostaglandins Other Lipid Mediat. pmid:17259081
Jin UH et al. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. 2007 Phytother Res pmid:17128437
Yang YY et al. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. 2007 Clin. Sci. pmid:17176248
Shemesh E et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. 2006 May-Jun Psychosomatics pmid:16684940
Tuominen OM et al. Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187. 2006 Jul-Aug Methods Find Exp Clin Pharmacol pmid:16894405
Wang LH et al. Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation. 2006 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:16445701
Wynn RL and Cook J Does ibuprofen block the cardioprotective effects of aspirin in dental patients? 2006 Jan-Feb Gen Dent pmid:16494111
Sailaja Devi MM and Das UN Effect of prostaglandins against alloxan-induced diabetes mellitus. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16297610
Kanda N and Watanabe S Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. 2006 Biochem. Pharmacol. pmid:16784723
Cook-Johnson RJ et al. Endothelial cell COX-2 expression and activity in hypoxia. 2006 Biochim. Biophys. Acta pmid:17046322
Faraday N et al. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. 2006 Am. J. Cardiol. pmid:16950183
Renda G et al. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. 2006 Clin. Pharmacol. Ther. pmid:16952493
Gabler NK et al. Dietary onion intake as part of a typical high fat diet improves indices of cardiovascular health using the mixed sex pig model. 2006 Plant Foods Hum Nutr pmid:17123162
Venturinelli ML et al. Platelet activation in different clinical forms of the coronary artery disease (role of P-selectin and others platelet markers in stable and unstable angina). 2006 Arq. Bras. Cardiol. pmid:17128313
Friton GM et al. Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. 2006 Vet. Rec. pmid:17056651
Ma K et al. [Study on comparative pharmacology of series of Muskone]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17061560
Myers SI et al. Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. 2006 J. Vasc. Surg. pmid:16520177
Fu JH et al. [Protective effects of saponines of stem and leaf of Panax notoginseng on acute myocardial ischemia in anaesthetic dogs]. 2006 Zhongguo Zhong Yao Za Zhi pmid:16548173
Kanazawa S et al. Aspirin reduces adverse effects of gefitinib. 2006 Anticancer Drugs pmid:16550000
Lee KS et al. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. 2006 Pharmacol. Res. pmid:16420980
Yin M et al. [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro]. 2006 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:16647015
Ahmad S et al. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. 2006 Eur. J. Pharmacol. pmid:16650843
Fontana P et al. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. 2006 J. Thromb. Haemost. pmid:16634751
Treiber G et al. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. 2006 Aliment. Pharmacol. Ther. pmid:16393293
Nakamura K et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. 2006 Cytokine pmid:17300951
Ohmori T et al. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. 2006 J. Thromb. Haemost. pmid:16706971
Perneby C et al. Dose- and time-dependent antiplatelet effects of aspirin. 2006 Thromb. Haemost. pmid:16601836
Ahmadzadehfar H et al. Passive cigarette smoking increases isoprostane formation. 2006 Life Sci. pmid:16165164
Lee KS et al. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. 2006 Life Sci. pmid:16153663
Eligini S et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. 2006 Cardiovasc. Res. pmid:16154551
Nobutoki T et al. Fluctuating hearing loss, episodic headache, and stroke with platelet hyperaggregability: coexistence of auditory neuropathy and cochlear hearing loss. 2006 Brain Dev. pmid:16168600
Santilli F et al. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. 2006 J. Am. Coll. Cardiol. pmid:16412866
Cao D et al. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. 2006 J. Nutr. Biochem. pmid:16098734
Sánchez M et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. 2006 J. Hypertens. pmid:16331104
Yang YY et al. Roles of anandamide in the hepatic microcirculation in cirrhotic rats. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:16407591
Cyrus T et al. Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. 2006 Atherosclerosis pmid:16326168
Mauri P et al. LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. 2006 J Pharm Biomed Anal pmid:16343838
Michel F et al. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16385086
Murphy KJ et al. Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. 2006 Asia Pac J Clin Nutr pmid:16837436